These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 16103166

  • 1. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
    Karlsson I, Grivel JC, Chen SS, Karlsson A, Albert J, Fenyö EM, Margolis LB.
    J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P.
    AIDS; 2007 Jun 19; 21(10):1263-72. PubMed ID: 17545702
    [Abstract] [Full Text] [Related]

  • 4. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC, Margolis LB.
    Nat Med; 1999 Mar 19; 5(3):344-6. PubMed ID: 10086394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A, Grivel JC, Biancotto A, Vanpouille C, Origgi F, Malnati MS, Schols D, Lusso P, Margolis LB.
    J Virol; 2007 Jan 19; 81(2):708-17. PubMed ID: 17065205
    [Abstract] [Full Text] [Related]

  • 8. Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue.
    Malkevitch N, McDermott DH, Yi Y, Grivel JC, Schols D, De Clercq E, Murphy PM, Glushakova S, Collman RG, Margolis L.
    Virology; 2001 Mar 15; 281(2):239-47. PubMed ID: 11277696
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
    Grivel JC, Ito Y, Fagà G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L.
    Nat Med; 2001 Nov 15; 7(11):1232-5. PubMed ID: 11689888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N, Nugeyre MT, Scott-Algara D, Cumont MC, Barré-Sinoussi F, Pancino G, Israël N.
    AIDS; 2006 Feb 28; 20(4):533-42. PubMed ID: 16470117
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus.
    Moriuchi M, Moriuchi H.
    J Med Virol; 2003 Nov 28; 71(3):343-6. PubMed ID: 12966538
    [Abstract] [Full Text] [Related]

  • 16. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 17. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N.
    J Virol; 2006 Oct 15; 80(20):10229-36. PubMed ID: 17005700
    [Abstract] [Full Text] [Related]

  • 18. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa.
    Meng G, Sellers MT, Mosteller-Barnum M, Rogers TS, Shaw GM, Smith PD.
    J Infect Dis; 2000 Sep 15; 182(3):785-91. PubMed ID: 10950772
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK, Gali Y, El-Abdellati A, Heyndrickx L, Janssens W, Vanham G.
    Virology; 2006 Mar 30; 347(1):65-74. PubMed ID: 16386774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.